Skip to content

← All stories

Earnings

Oncopeptides Q2 2026 slides: 62% sales growth, 3rd-line expansion

1 source ·2 articles ·1h ago

Covered by 1 outlet

All coverage · 2 articles

Investing.com News ·1h ago

Oncopeptides Q2 2026 slides: 62% sales growth, 3rd-line expansion

Investing.com Canada ·1h ago

Earnings call transcript: Oncopeptides Q2 2026 sales jump 62% as stock rises